Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy
-
Published:2023-10
Issue:
Volume:Volume 10
Page:1827-1837
-
ISSN:2253-5969
-
Container-title:Journal of Hepatocellular Carcinoma
-
language:en
-
Short-container-title:JHC
Author:
Luo Meng-ChaoORCID,
Wu Jia-YiORCID,
Wu Jun-Yi,
Lin Zhong-Tai,
Li Yi-Nan,
Zeng Zhen-XinORCID,
Wei Shao-Ming,
Yan Mao-Lin
Publisher
Informa UK Limited
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献